哈药股份(600664)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

600664 哈药股份

已收盘 09-03 15:00:00

{"stockData":{"symbol":"600664","market":"SH","secType":"STK","nameCN":"哈药股份","latestPrice":8.55,"timestamp":1788418800000,"preClose":9.24,"halted":0,"volume":443030449,"delay":0,"changeRate":-0.0747,"floatShares":2519000000,"shares":2519000000,"eps":0.2034,"marketStatus":"已收盘","change":-0.69,"latestTime":"09-03 15:00:00","open":8.91,"high":9.15,"low":8.32,"amount":3782000000,"amplitude":0.0898,"askPrice":8.55,"askSize":3198,"bidPrice":8.54,"bidSize":962,"shortable":0,"etf":0,"ttmEps":0.2034,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1788485400000},"marketStatusCode":5,"adr":0,"adjPreClose":9.24,"symbolType":"stock","openAndCloseTimeList":[[1788399000000,1788406200000],[1788411600000,1788418800000]],"highLimit":10.16,"lowLimit":8.32,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":2518509876,"isCdr":false,"pbRate":3.53,"roa":"--","peRate":42.035398,"roe":"6.96%","epsLYR":0.14,"committee":-0.699668,"marketValue":21533000000,"turnoverRate":0.1759,"status":1,"floatMarketCap":21533000000},"requestUrl":"/m/hq/s/600664/","defaultTab":"news","newsList":[{"id":"2664253908","title":"异动快报：哈药股份（600664）9月3日11点20分触及跌停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2664253908","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664253908?lang=zh_cn&edition=full","pubTime":"2026-09-03 11:25","pubTimestamp":1788405928,"startTime":"0","endTime":"0","summary":"证券之星9月3日盘中消息，11点20分哈药股份（600664）触及跌停板。其所属行业化学制药目前下跌。领涨股为美诺华。该股为跨境电商，振兴东北，流感概念热股，当日跨境电商概念上涨0.02%。9月2日的资金流向数据方面，主力资金净流入632.05万元，占总成交额0.26%，游资资金净流入2127.65万元，占总成交额0.88%，散户资金净流出2759.7万元，占总成交额1.14%。近5日资金流向一览见下表：哈药股份主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300016654.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0188","600664","BK0012","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663010694","title":"每周股票复盘：哈药股份（600664）Q2净利暴增432.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663010694","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663010694?lang=zh_cn&edition=full","pubTime":"2026-08-30 02:27","pubTimestamp":1788028028,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，哈药股份报收于9.0元，较上周的8.17元上涨10.16%。股本股东变化截至2026年6月30日，哈药股份股东户数为10.98万户，较3月31日增加1.65万户，增幅17.73%。业绩披露要点2026年上半年，哈药股份主营收入82.96亿元，同比上升2.1%；归母净利润4.1亿元，同比上升57.99%；扣非净利润3.55亿元，同比上升45.39%。第二季度单季主营收入41.2亿元，同比上升4.31%；单季归母净利润2.49亿元，同比上升432.73%；单季扣非净利润2.01亿元，同比上升401.57%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000000841.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0012","BK0188","600664"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662203446","title":"【机构调研记录】淳厚基金调研哈药股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2662203446","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662203446?lang=zh_cn&edition=full","pubTime":"2026-08-28 08:16","pubTimestamp":1787876174,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及8月27日披露的机构调研信息，淳厚基金近期对1家上市公司进行了调研，相关名单如下：1）哈药股份 调研纪要：公司医药工业板块持续优化全域营销策略与业务布局，推动终端纯销转型，主要产品销售增长带动业绩上升。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800015300.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0012","BK0188","BK0239","600664"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662828170","title":"股市必读：哈药股份（600664）8月27日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2662828170","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662828170?lang=zh_cn&edition=full","pubTime":"2026-08-28 00:58","pubTimestamp":1787849894,"startTime":"0","endTime":"0","summary":"截至2026年8月27日收盘，哈药股份报收于8.75元，上涨6.97%，换手率14.99%，成交量377.46万手，成交额32.28亿元。当日关注点交易信息汇总：8月27日主力资金净流出5092.85万元，占总成交额1.58%。机构调研要点：哈药股份2026年上半年销售费用同比下降8.37%、管理费用同比下降4.93%，费用管控成效显著。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800002769.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","600664","BK0028","BK0188","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662740698","title":"哈药股份（600664）2026年中报简析：营收净利润同比双双增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2662740698","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662740698?lang=zh_cn&edition=full","pubTime":"2026-08-27 06:05","pubTimestamp":1787781959,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期哈药股份发布2026年中报。根据财报显示，哈药股份营收净利润同比双双增长。截至本报告期末，公司营业总收入82.96亿元，同比上升2.1%，归母净利润4.1亿元，同比上升57.99%。应交税费变动幅度为64.72%,原因:公司本报告期因公司营业收入及利润总额增长带来应交增值税及所得税增加。经营活动产生的现金流量净额变动幅度为67.24%,原因:公司本报告期销售商品收到的现金同比增加。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700010931.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600664"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662756334","title":"哈药股份(600664.SH)发布半年度业绩，归母净利润4.1亿元，同比增长57.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662756334","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662756334?lang=zh_cn&edition=full","pubTime":"2026-08-26 00:05","pubTimestamp":1787673903,"startTime":"0","endTime":"0","summary":"智通财经APP讯，哈药股份(600664.SH)发布2026年半年度报告，报告期内，公司实现营业收入82.96亿元，同比增长2.1%;归属于上市公司股东的净利润4.1亿元，同比增长57.99%;归属于上市公司股东的扣除非经常性损益的净利润3.55亿元，同比增长45.39%;基本每股收益0.1629元。报告期内，公司营业收入同比增加2.1%，主要为本报告期医药商业板块持续巩固现有规模优势，批发与零售业务均同比增长所致。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1485608.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"哈药股份(600664.SH)发布半年度业绩，归母净利润4.1亿元，同比增长57.99%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600664"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662758562","title":"哈药股份（600664）披露2026年半年度报告，8月25日股价下跌0.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662758562","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662758562?lang=zh_cn&edition=full","pubTime":"2026-08-25 22:02","pubTimestamp":1787666548,"startTime":"0","endTime":"0","summary":"截至2026年8月25日收盘，哈药股份报收于8.21元，较前一交易日下跌0.12%，最新总市值为206.77亿元。该股当日开盘8.1元，最高8.39元，最低7.92元，成交额达24.13亿元，换手率为11.66%。近日，哈药集团股份有限公司披露《2026年半年度报告》。公告显示，公司总资产为14,635,465,744.98元，较上年度末增长2.43%；归属于上市公司股东的净资产为6,105,875,251.15元，同比增长7.34%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500050015.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","600664","BK0012","BK0028","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662352567","title":"哈药股份2026年半年报：主业提质增效，净利增近六成","url":"https://stock-news.laohu8.com/highlight/detail?id=2662352567","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662352567?lang=zh_cn&edition=full","pubTime":"2026-08-25 18:37","pubTimestamp":1787654255,"startTime":"0","endTime":"0","summary":"财报数据显示，报告期公司实现营业收入82.96亿元，同比增长2.10%；归母净利润4.10亿元，同比增长57.99%；扣非净利润3.55亿元，同比增长45.39%。医药商业板块主要由控股子公司人民同泰运营，报告期内实现营业收入54.08亿元，同比增长5.03%；归母净利润0.81亿元，同比增长11.60%，其中零售业务收入同比增长15.66%，DTP专业药房及院边店布局成效显现。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1787649803397933607","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["600664","BK0188","BK0239","BK0028","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661924322","title":"股市必读：哈药股份（600664）登8月21日交易所龙虎榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2661924322","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661924322?lang=zh_cn&edition=full","pubTime":"2026-08-24 00:58","pubTimestamp":1787504293,"startTime":"0","endTime":"0","summary":"截至2026年8月21日收盘，哈药股份报收于8.17元，下跌10.02%，换手率17.81%，成交量448.66万手，成交额36.8亿元。交易信息汇总：哈药股份因日收盘价格跌幅偏离值达7%登上龙虎榜，系近5个交易日内第2次上榜。公司公告汇总哈药集团股份有限公司股票交易严重异常波动暨风险提示公告截至2026年8月20日收盘，哈药集团股份有限公司股票连续30个交易日内日收盘价格涨幅偏离值累计达到200%，属于股票交易严重异常波动情形。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400000757.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","600664","BK0012","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661269920","title":"哈药股份（600664）披露股票交易严重异常波动暨风险提示公告，8月21日股价下跌10.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661269920","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661269920?lang=zh_cn&edition=full","pubTime":"2026-08-21 17:36","pubTimestamp":1787305010,"startTime":"0","endTime":"0","summary":"截至2026年8月21日收盘，哈药股份报收于8.17元，较前一交易日下跌10.02%，最新总市值为205.76亿元。该股当日开盘8.17元，最高8.55元，最低8.17元，成交额达36.8亿元，换手率为17.81%。哈药集团股份有限公司于近日披露《股票交易严重异常波动暨风险提示公告》。公告显示，截至2026年8月20日收盘，公司股票连续30个交易日内日收盘价格涨幅偏离值累计达到200%，属于股票交易严重异常波动情形。董事会确认无未披露事项。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100032002.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0012","BK0239","600664","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661225609","title":"600664，开盘跌停！27万手封单","url":"https://stock-news.laohu8.com/highlight/detail?id=2661225609","media":"滚动播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661225609?lang=zh_cn&edition=full","pubTime":"2026-08-21 10:10","pubTimestamp":1787278200,"startTime":"0","endTime":"0","summary":"8月21日，A股三大指数集体低开，随后走势分化。截至发稿时，沪指跌0.14%，深成指涨0.18%，创业板指涨0.74%，科创综指跌0.27%。港股市场震荡拉升，MiniMax、华虹宏力、小米集团等表现活跃。国金证券表示，创新药企业正逐步进入商业化兑现的黄金窗口期。政策层面，生物医药被列为“新兴支柱产业”，2026年版基药目录首次纳入国产一类创新药，为商业化放量打通制度性通道。资金面上，非医药基金对创新药关注度显著提升，医药ETF持续获得净流入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-08-21/doc-ininztwt6475582.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0188","BK0012","BK0239","600664","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660328879","title":"8月20日哈药股份（600664）龙虎榜数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2660328879","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660328879?lang=zh_cn&edition=full","pubTime":"2026-08-20 17:57","pubTimestamp":1787219837,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年8月20日公布的交易公开信息显示，哈药股份因有价格涨跌幅限制的连续30个交易日内收盘价格涨幅偏离值累计达到200%的证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年8月20日收盘，哈药股份报收于9.08元，上涨0.22%，换手率19.37%，成交量487.86万手，成交额44.38亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082000032649.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0012","600664","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658973031","title":"8月12日哈药股份现255.49万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2658973031","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658973031?lang=zh_cn&edition=full","pubTime":"2026-08-12 17:33","pubTimestamp":1786527223,"startTime":"0","endTime":"0","summary":"证券之星消息，8月12日哈药股份发生大宗交易，交易数据如下：大宗交易成交价格8.81元，成交29万股，成交金额255.49万元，买方营业部为中信证券股份有限公司总部(非营业场所)，卖方营业部为中信证券股份有限公司深圳深南中路中信大厦证券营业部。近三个月该股共发生1笔大宗交易，合计成交2900.0手。该股近期无解禁股上市。截至2026年8月12日收盘，哈药股份(600664)报收于8.81元，上涨6.53%，换手率23.75%，成交量598.07万手，成交额51.91亿元。该股最近90天内无机构评级。本文数据来源于上海证券交易所大宗交易信息披露，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200030068.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600664","BK0188","BK0239","BK0028","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658999316","title":"8月11日哈药股份（600664）龙虎榜数据：北向资金净买入3.12亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2658999316","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658999316?lang=zh_cn&edition=full","pubTime":"2026-08-11 17:38","pubTimestamp":1786441132,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年8月11日公布的交易公开信息显示，哈药股份因非S证券连续三个交易日内收盘价格涨幅偏离值累计达到20%的证券，有价格涨跌幅限制的日换手率达到20%的前五只证券登上龙虎榜。此次是近5个交易日内第2次上榜。截至2026年8月11日收盘，哈药股份报收于8.27元，上涨9.97%，已连续涨停3天，换手率26.95%，成交量678.75万手，成交额54.95亿元。从龙虎榜公布的当日买卖数据来看，北向资金合计净买入3.12亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081100028494.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK0012","600664","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658981295","title":"近一个月猛涨145%！哈药股份何以走出翻倍行情？","url":"https://stock-news.laohu8.com/highlight/detail?id=2658981295","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658981295?lang=zh_cn&edition=full","pubTime":"2026-08-10 17:00","pubTimestamp":1786352401,"startTime":"0","endTime":"0","summary":"近期，在创新药板块带动下，哈药股份股价迎来年内最高涨幅。可以认为，哈药股份本轮翻倍行情是业绩反转、赛道风口多重逻辑共振的结果，核心上涨逻辑具备持续性。哈药股份在报告中称，业绩增长主要受医药工业板块业绩提升及全渠道营销发力影响。","market":"fut","thumbnail":" http://caiji.3g.cnfol.com/colect/202608/10/20260810740000.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202608/10/20260810740000.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20260810/32330524.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0012","BK0239","BK0028","600664","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656092537","title":"两款新品拟中标国家级集采 哈药股份迎来业绩与管线双重突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2656092537","media":"市场资讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656092537?lang=zh_cn&edition=full","pubTime":"2026-08-04 18:58","pubTimestamp":1785841080,"startTime":"0","endTime":"0","summary":"7月31日，第十二批国家药品集采首轮拟中选结果公布，老牌药企哈药股份收获重大利好，旗下富马酸伏诺拉生片、注射用头孢他啶阿维巴坦钠两款 2026年6月刚获批的新品成功入围，叠加上半年亮眼的业绩预增，公司研发管线进入集中兑现期，成长逻辑持续强化。长期来看，本次双药集采中标是哈药研发投入进入收获期的标志性信号。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-08-04/doc-inimeefm1991224.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0012","BK0028","BK0188","BK0239","600664"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656320564","title":"哈药股份最新公告：两个产品拟中标第十二批全国药品集中采购","url":"https://stock-news.laohu8.com/highlight/detail?id=2656320564","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656320564?lang=zh_cn&edition=full","pubTime":"2026-08-03 18:00","pubTimestamp":1785751218,"startTime":"0","endTime":"0","summary":"哈药股份(600664.SH)公告称，公司所属哈药总厂和哈药六厂参加第十二批全国药品集中采购，注射用头孢他啶阿维巴坦钠和富马酸伏诺拉生片拟中标，采购周期至2029年12月31日。上述产品尚未销售，若后续签订采购合同，将有利于快速打开国内市场，提升品牌影响力。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080300025360.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0188","600664","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655886850","title":"哈药股份最新公告：所属企业获硫酸钾化学原料药上市批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2655886850","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655886850?lang=zh_cn&edition=full","pubTime":"2026-07-29 16:47","pubTimestamp":1785314825,"startTime":"0","endTime":"0","summary":"哈药股份(600664.SH)公告称，公司所属企业哈药生物收到国家药监局颁发的硫酸钾《化学原料药上市申请批准通知书》。硫酸钾为硫酸镁钠钾口服用浓溶液的原料药，用于渗透性导泻。截至公告日，国内共有26家企业硫酸钾原料药登记状态为“A”。该批准有利于夯实公司原料制剂一体化战略，丰富产品管线，但生产销售受市场环境等因素影响存在不确定性。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072900027542.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0028","600664","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655527668","title":"哈药股份：公司于各期定期报告中披露对应时点的股东人数信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2655527668","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655527668?lang=zh_cn&edition=full","pubTime":"2026-07-29 15:33","pubTimestamp":1785310386,"startTime":"0","endTime":"0","summary":"证券之星消息，哈药股份07月29日在投资者关系平台上答复投资者关心的问题。为保障全体投资者平等知情权，公司于各期定期报告中披露对应时点的股东人数信息。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072900020543.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0028","600664","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654016483","title":"7月27日哈药股份（600664）龙虎榜数据：北向资金净卖出2356.06万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2654016483","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654016483?lang=zh_cn&edition=full","pubTime":"2026-07-27 17:39","pubTimestamp":1785145154,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年7月27日公布的交易公开信息显示，哈药股份因有价格涨跌幅限制的日换手率达到20%的前五只证券登上龙虎榜。此次是近5个交易日内第4次上榜。截至2026年7月27日收盘，哈药股份报收于5.64元，上涨4.44%，换手率20.49%，成交量515.96万手，成交额28.52亿元。从龙虎榜公布的当日买卖数据来看，北向资金合计净卖出2356.06万元。深股通专用、沪股通专用为北向资金的交易席位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072700023074.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK0012","600664","BK0188"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1788421020712,"stockEarnings":[{"period":"1week","weight":0.1296},{"period":"1month","weight":0.5426},{"period":"3month","weight":1.9148},{"period":"6month","weight":1.6476},{"period":"1year","weight":1.4772},{"period":"ytd","weight":1.6783}],"compareEarnings":[{"period":"1week","weight":0.0074},{"period":"1month","weight":0.0346},{"period":"3month","weight":-0.0287},{"period":"6month","weight":-0.0443},{"period":"1year","weight":0.0216},{"period":"ytd","weight":-0.0069}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"哈药集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"109809人(较上一季度增加17.73%)","perCapita":"22935股","listingDate":"1993-06-29","address":"黑龙江省哈尔滨市呼兰区利民开发区利民西四大街68号","registeredCapital":"251850万元","survey":"　　哈药集团股份有限公司的主营业务是医药研发与制造、批发与零售业务。公司的主要产品是复方葡萄糖酸钙口服溶液、葡萄糖酸锌口服溶液、哈药牌钙铁锌口服液、人促红素注射液、阿莫西林胶囊、注射用头孢曲松钠、注射用青霉素钠、双黄连口服液、祛风骨痛凝胶膏、拉西地平片、健安喜Vitapak每日营养包、健安喜97%高纯度鱼油软胶囊、哈药生物重组胶原蛋白凝时抗皱次抛精华液、哈药生物玻尿酸补水保湿面膜。","listedPrice":1},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"哈药股份(600664)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供哈药股份(600664)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"哈药股份,600664,哈药股份股票,哈药股份股票老虎,哈药股份股票老虎国际,哈药股份行情,哈药股份股票行情,哈药股份股价,哈药股份股市,哈药股份股票价格,哈药股份股票交易,哈药股份股票购买,哈药股份股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"哈药股份(600664)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供哈药股份(600664)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}